Niranjan Kanesa-thasan
Technik-/Wissenschafts-/F&E-Leiter bei ICOSAVAX, INC.
Aktive Positionen von Niranjan Kanesa-thasan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ICOSAVAX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 | - |
Karriereverlauf von Niranjan Kanesa-thasan
Ehemalige bekannte Positionen von Niranjan Kanesa-thasan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Kanesa LLC | Gründer | 01.11.2017 | 01.08.2019 |
| GSK Vaccines | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.08.2017 |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.2007 | 01.01.2015 |
Ausbildung von Niranjan Kanesa-thasan
| The Johns Hopkins University | Undergraduate Degree |
| Uniformed Services University of the Health Sciences | Graduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
| GSK Vaccines | |
| Kanesa LLC |
- Börse
- Insiders
- Niranjan Kanesa-thasan
- Erfahrung
